Cargando…

Myeloma Bone Disease

Detalles Bibliográficos
Autores principales:	Sanderson, Ralph D, Epstein, Joshua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR) 2009
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276340/ https://www.ncbi.nlm.nih.gov/pubmed/19839769 http://dx.doi.org/10.1359/jbmr.090901

Ejemplares similares

Multiple Myeloma as a Bone Disease? The Tissue Disruption-Induced Cell Stochasticity (TiDiS) Theory
por: Capp, Jean-Pascal, et al.
Publicado: (2020)

The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
por: Gámez, Beatriz, et al.
Publicado: (2021)

The Ins and Outs of Endosteal Niche Disruption in the Bone Marrow: Relevance for Myeloma Oncogenesis
por: Capp, Jean-Pascal, et al.
Publicado: (2023)

Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
por: Anderson, Kenneth C., et al.
Publicado: (2021)

Optimizing carfilzomib use in multiple myeloma treatment
por: Yoon, Sung-Soo
Publicado: (2019)

Steps towards a Multiple Myeloma Cure?
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
por: Davies, Faith E., et al.
Publicado: (2022)

Multiple myeloma in Korea: risk stratification and initial treatment
por: Yoon, Sung-Soo
Publicado: (2018)

Clinician‐driven research priorities in bone and joint infection: perspectives of orthopaedic surgeons and infectious diseases physicians
por: Davis, Joshua S, et al.
Publicado: (2022)

SARS-CoV-2 Vaccines in Patients With Multiple Myeloma
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Response to “The Role of FcRn in the Pharmacokinetics of Biologics in Patients with Multiple Myeloma”
por: Xu, Xu Steven, et al.
Publicado: (2017)

ImmunoPET in Multiple Myeloma—What? So What? Now What?
por: Bailly, Clément, et al.
Publicado: (2020)

The Immune Microenvironment in Multiple Myeloma Progression at a Single-cell Level
por: Schinke, Carolina, et al.
Publicado: (2023)

The great dental amalgam debate
por: Sanderson, Susie
Publicado: (2022)

Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020
por: Du, Jianhua, et al.
Publicado: (2021)

Understanding the Mechanisms of Resistance to T Cell-based Immunotherapies to Develop More Favorable Strategies in Multiple Myeloma
por: Ahn, Sungwoo, et al.
Publicado: (2021)

Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora’s Box of Multiple Myeloma
por: Garcés, Juan-José, et al.
Publicado: (2022)

Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
por: Epstein, Robert S
Publicado: (2021)

Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age
por: Engelhardt, Monika, et al.
Publicado: (2020)

Guest Editorial: Climate Change: Healthy Solutions
por: Epstein, Paul R.
Publicado: (2007)

Developing next generation immunomodulatory drugs and their combinations in multiple myeloma
por: Thakurta, Anjan, et al.
Publicado: (2021)

Recruiting to preclinical Alzheimer's disease clinical trials through registries
por: Grill, Joshua D.
Publicado: (2017)

Identification of Immunoglobulin Gene Rearrangement Biomarkers in Multiple Myeloma through cfDNA-Based Liquid Biopsy Using tchDNA-Seq
por: Buenache, Natalia, et al.
Publicado: (2023)

What is an emergency? Neonicotinoids and emergency situations in plant protection in the EU
por: Epstein, Yaffa, et al.
Publicado: (2022)

Myeloma Bone Disease: The Osteoblast in the Spotlight
por: Andrews, Rebecca E., et al.
Publicado: (2021)

A critical role for the NFkB pathway in multiple myeloma
por: Demchenko, Yulia N., et al.
Publicado: (2010)

Osteoclast-derived SLIT3 is a coupling factor linking bone resorption to bone formation
por: Koh, Jung-Min
Publicado: (2018)

Defining Attachment and Bonding: Overlaps, Differences and Implications for Music Therapy Clinical Practice and Research in the Neonatal Intensive Care Unit (NICU)
por: Ettenberger, Mark, et al.
Publicado: (2021)

Modeling Alzheimer’s disease: considerations for a better translational and replicable mouse model
por: Cho, Joshua D., et al.
Publicado: (2022)

Stem cells for the repair and regeneration of bone
por: Nauth, Aaron, et al.
Publicado: (2012)

Cell Scaffolds for Bone Tissue Engineering
por: Iijima, Kazutoshi, et al.
Publicado: (2020)

T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma
por: Verkleij, Christie P.M., et al.
Publicado: (2020)

Potential Psychological and Biological Mechanisms Underlying the Effectiveness of Neonatal Music Therapy during Kangaroo Mother Care for Preterm Infants and Their Parents
por: Bieleninik, Łucja, et al.
Publicado: (2021)

Cardiovascular disease: The rise of the genetic risk score
por: Knowles, Joshua W., et al.
Publicado: (2018)

Osteocalcin promotes bone mineralization but is not a hormone
por: Manolagas, Stavros C.
Publicado: (2020)

Osteoimmunity-regulating biomaterials promote bone regeneration
por: Liu, Zongtai, et al.
Publicado: (2023)

Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma
por: Hu, Bo, et al.
Publicado: (2013)

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma
por: Ramani, Vishnu C., et al.
Publicado: (2015)

Genetics provides new individualized therapeutic targets for Parkinson’s disease
por: Garcia, Eric Joshua, et al.
Publicado: (2020)

The role of bone‐modifying agents in myeloma bone disease
por: Lu, Huifang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nvjh16isang8b0rcv1shdcfrr3